Abstract: Processes and methods of purifying or separating Single Domain Antigen Binding (SDAB) molecules that include one or more single binding domains (e.g., one or more nanobody molecules), substantially devoid of a complementary antibody domain and an immunoglobulin constant region, using Protein A-based affinity chromatography, are disclosed.

Abstract: This disclosure relates to methods and kits for karyotyping in which chromosomes are interrogated by amplifying loci that are not within copy number variable regions thereof.

Abstract: This disclosure relates to methods and kits for karyotyping in which chromosomes are interrogated by amplifying loci that are not within copy number variable regions thereof.

Abstract: Processes and methods of purifying or separating Single Domain Antigen Binding (SDAB) molecules that include one or more single binding domains (e.g., one or more nanobody molecules), substantially devoid of a complementary antibody domain and an immunoglobulin constant region, using Protein A-based affinity chromatography, are disclosed.

Abstract: Processes and methods of purifying or separating Single Domain Antigen Binding (SDAB) molecules that include one or more single binding domains (e.g., one or more nanobody molecules), substantially devoid of a complementary antibody domain and an immunoglobulin constant region, using Protein A-based affinity chromatography, are disclosed.

Abstract: This disclosure relates to methods and kits for karyotyping in which chromosomes are interrogated by amplifying loci that are not within copy number variable regions thereof.

Abstract: Processes and methods of purifying or separating Single Domain Antigen Binding (SDAB) molecules that include one or more single binding domains (e.g., one or more nanobody molecules), substantially devoid of a complementary antibody domain and an immunoglobulin constant region, using Protein A-based affinity chromatography, are disclosed.

Abstract: The present invention is in the field of molecular biology and genetics. More specifically, the invention relates to human ?N p73, a novel gene associated with apoptosis regulation. The present invention provides and includes nucleic acid molecules, proteins and antibodies associated with ?N p73 and methods utilizing such agents, for example in gene isolation, gene analysis, the production of transformed cell lines, and transgenic cells modified to over- or under-express ?N p73. Moreover, the present invention includes use of the agents of the invention for the diagnosis, prevention and treatment of diseases associated with decreases or increased apoptosis.

Abstract: A current transformer for outdoor high-voltage installations which is insulated by pressurized gas includes a metallic top housing mounted to a hollow porcelain insulator. The top housing contains a primary conductor which is surrounded by coils of the secondary circuit. The secondary terminal leads are installed in a grounded lead-through tube which is disposed within the hollow porcelain insulator. In order to increase the dielectric strength of the current transformer, the space which is enclosed by the top housing and the porcelain insulator is divided into a high-pressure region and a low-pressure region, the former region including zones which are exposed to high voltages, in particular the interior of the top housing, and which are bounded throughout by metal and a mechanically strong insulating material, such as a casting region.